Antitumor activity of cyclin‐dependent kinase inhibitor alsterpaullone in Epstein‐Barr virus‐associated lymphoproliferative disorders

Takahiro Watanabe(Nagoya University), Hiroshi Kimura(Nagoya University)
Cancer Science
November 19, 2019
Cited by 15


Related Papers